We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.62B
AUM Growth
-$2.78B
Cap. Flow
-$2.47B
Cap. Flow %
-43.88%
Top 10 Hldgs %
56.27%
Holding
465
New
101
Increased
59
Reduced
84
Closed
204

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$44.1M
2
HRMY icon
Harmony Biosciences
HRMY
+$36.9M
3
TVTX icon
Travere Therapeutics
TVTX
+$33.9M
4
MDLN
Medline Inc
MDLN
+$22.4M
5
META icon
Meta Platforms (Facebook)
META
+$20.9M

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$70.6M
2
IMVT icon
Immunovant
IMVT
+$56.5M
3
XRAY icon
Dentsply Sirona
XRAY
+$53.6M
4
GEHC icon
GE HealthCare
GEHC
+$53.1M
5
PTCT icon
PTC Therapeutics
PTCT
+$51.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.27%
2 Technology 7.29%
3 Consumer Discretionary 4.25%
4 Communication Services 1.58%
5 Consumer Staples 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CINF icon
301
Cincinnati Financial
CINF
$28B
– –
-1,791
Closed -$293K
CLBT icon
302
Cellebrite
CLBT
$3.85B
– –
-16,759
Closed -$302K
CMCSA icon
303
Comcast
CMCSA
$85B
– –
-8,946
Closed -$251K
CME icon
304
CME Group
CME
$88.5B
– –
-1,081
Closed -$295K
CNA icon
305
CNA Financial
CNA
$14.1B
– –
-6,280
Closed -$300K
CNTA
306
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-500,000
Closed -$12.5M
COCO icon
307
Vita Coco
COCO
$4.18B
– –
-14,540
Closed -$771K
COO icon
308
Cooper Companies
COO
$14B
– –
-17,888
Closed -$1.47M
COR icon
309
Cencora
COR
$59.9B
– –
-28,000
Closed -$9.46M
CORZ icon
310
Core Scientific
CORZ
$6.66B
– –
-19,589
Closed -$285K
CPB icon
311
Campbell Soup
CPB
$6.58B
– –
-7,586
Closed -$211K
CRBG icon
312
Corebridge Financial
CRBG
$14.4B
– –
-10,853
Closed -$327K
CRC icon
313
California Resources
CRC
$4.69B
– –
-6,086
Closed -$272K
CRIS icon
314
Curis
CRIS
$9.02M
– –
-44,179
Closed -$872K
CUZ icon
315
Cousins Properties
CUZ
$5.23B
– –
-11,566
Closed -$298K
CVS icon
316
CVS Health
CVS
$137B
– –
-295,589
Closed -$23.5M
CVX icon
317
Chevron
CVX
$373B
– –
-2,531
Closed -$386K
CW icon
318
Curtiss-Wright
CW
$26.1B
– –
-469
Closed -$259K
CYBR
319
DELISTED
CyberArk
CYBR
– –
-908
Closed -$405K
DBX icon
320
Dropbox
DBX
$7.14B
– –
-10,817
Closed -$301K
DD icon
321
DuPont de Nemours
DD
$18.3B
– –
-2,470
Closed -$298K
DECK icon
322
Deckers Outdoor
DECK
$14.8B
– –
-8,409
Closed -$872K
DGX icon
323
Quest Diagnostics
DGX
$23.3B
– –
-1,351
Closed -$234K
DHI icon
324
D.R. Horton
DHI
$42.4B
– –
-1,664
Closed -$240K
DHR icon
325
Danaher
DHR
$144B
– –
-107,035
Closed -$24.5M
11 12
13
14 15

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Armistice Capital held 465 positions worth $5.62B, down 33% from $8.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital withdrew a net $2.47B in Q1 2026, closing 204 positions and reducing 84 holdings. Its most notable exit was argenx, an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in UnitedHealth worth $40M.

  • Armistice Capital's largest Q1 2026 buy was UnitedHealth: 148,000 shares worth $40M.
  • Armistice Capital added most to Harmony Biosciences in Q1 2026, an estimated $36.9M increase.
  • Armistice Capital's biggest Q1 2026 reduction was Kenvue, cutting an estimated $70.6M.
  • Armistice Capital fully exited argenx in Q1 2026, selling an estimated $48.8M.
  • Armistice Capital's ten largest holdings make up 56% of its $5.62B portfolio in Q1 2026.
  • Armistice Capital opened 101 new positions and closed 204 in Q1 2026.
  • Armistice Capital's portfolio value fell 33% quarter-over-quarter to $5.62B.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.